2012•Nanjing Zhongyiyao Daxue xuebaoRequires access

30 Cases of Rheumatoid Arthritis Treated by Qiwei Tongbi Oral Liquid

Wei Hu

Open publisher page 2 citations

Abstract

OBJECTIVE To observe clinical efficacy and safety of Qiwei Tongbi Oral Liquid on rheumatoid arthritis belonging to deficiency of liver and kidney,wind and dampness blocking meridians.METHODS 60 patients were divided into 2 groups.30 cases in control group were administrated with methotrexate,hydroxychloroquine sulfate and celecoxib;while 30 cases in treatment group were given methotrexate,hydroxychloroquine sulfate and Qiwei Tongbi Oral Liquid.The treatment course was 8 weeks.RESULTS The total effective rate of treatment group was 86.67%;the control group was 73.33%,P0.05.Results of ESR,C-reactive protein,IgG,joint pain,joint swelling,movement disorder and VAS score of treatment group were better than control group(P0.05).CONCLUSION Qiwei Tongbi Oral Liquid was efficacy and safety on rheumatoid arthritis belonging to deficiency of liver and kidney,wind and dampness blocking meridians.

About this research paper

What this paper is about

OBJECTIVE To observe clinical efficacy and safety of Qiwei Tongbi Oral Liquid on rheumatoid arthritis belonging to deficiency of liver and kidney,wind and dampness blocking meridians.METHODS 60 patients were divided into 2 groups.30 cases in control group were administrated with methotrexate,hydroxychloroquine sulfate and celecoxib;while 30 cases in treatment group were given methotrexate,hydroxychloroquine sulfate and Qiwei Tongbi Oral Liquid.The treatment course was 8 weeks.RESULTS The total effective rate of treatment group was 86.67%;the control group was 73.33%,P0.05.Results of ESR,C-reactive protein,IgG,joint pain,joint swelling,movement disorder and VAS score of treatment group were better than control group(P0.05).CONCLUSION Qiwei Tongbi Oral Liquid was efficacy and safety on rheumatoid arthritis belonging to deficiency of liver and kidney,wind and dampness blocking meridians.

Why it matters

OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVE To observe clinical efficacy and safety of Qiwei Tongbi Oral Liquid on rheumatoid arthritis belonging to deficiency of liver and kidney,wind and dampness blocking meridians.METHODS 60 patients were divided into 2 groups.30 cases in control group were administrated with methotrexate,hydroxychloroquine sulfate and celecoxib;while 30 cases in treatment group were given methotrexate,hydroxychloroquine sulfate and Qiwei Tongbi Oral Liquid.The treatment course was 8 weeks.RESULTS The total effective rate of treatment group was 86.67%;the control group was 73.33%,P0.05.Results of ESR,C-reactive protein,IgG,joint pain,joint swelling,movement disorder and VAS score of treatment group were better than control group(P0.05).CONCLUSION Qiwei Tongbi Oral Liquid was efficacy and safety on rheumatoid arthritis belonging to deficiency of liver and kidney,wind and dampness blocking meridians.

Key concepts: Medicine, Rheumatoid arthritis, Methotrexate, Hydroxychloroquine, Internal medicine, Joint pain, Gastroenterology, Surgery

Related papers

Back to paper searchBrowse research topicsOriginal source
30 Cases of Rheumatoid Arthritis Treated by Qiwei Tongbi Oral Liquid — Research Paper | ScholarLens